Figure 4From: Phytalgic®, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trialTotal WOMAC scores (mean ± SEM) at preinclusion and after one, two or three months of treatment. Randomized to active or placebo treatment. Difference from preinclusion was significant at all subsequent times for active, but not for placebo.Back to article page